Indication
Parkinson Disease
1 clinical trial
1 product
Clinical trial
A Multicentre, Phase 3, Clinical Study to Compare the Striatal Uptake of a Dopamine Transporter Radioligand, DaTSCAN™ Ioflupane (123I) Injection, After Intravenous Administration to Chinese Patients With a Diagnosis of Parkinson's Disease, Multiple System Atrophy, Progressive Supranuclear Palsy, or Essential Tremor and to Healthy ControlsStatus: Completed, Estimated PCD: 2021-12-20
Product
DaTSCAN Ioflupane